Rockefeller Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.43M | Buy |
17,948
+339
| +2% | +$103K | 0.01% | 764 |
|
|
2025
Q1 | $5.83M | Sell |
17,609
-601
| -3% | -$199K | 0.01% | 697 |
|
|
2024
Q4 | $5.62M | Buy |
18,210
+122
| +0.7% | +$37.6K | 0.01% | 692 |
|
|
2024
Q3 | $3.84M | Sell |
18,088
-1,000
| -5% | -$212K | 0.01% | 788 |
|
|
2024
Q2 | $5.35M | Sell |
19,088
-16,073
| -46% | -$4.5M | 0.02% | 668 |
|
|
2024
Q1 | $9.39M | Buy |
35,161
+2,121
| +6% | +$566K | 0.03% | 522 |
|
|
2023
Q4 | $7.64M | Buy |
33,040
+14,926
| +82% | +$3.45M | 0.03% | 534 |
|
|
2023
Q3 | $2.65M | Buy |
18,114
+6,289
| +53% | +$918K | 0.01% | 743 |
|
|
2023
Q2 | $2.73M | Buy |
11,825
+1,735
| +17% | +$401K | 0.01% | 746 |
|
|
2023
Q1 | $2.44M | Buy |
+10,090
| New | +$2.44M | 0.01% | 748 |
|